martes, 6 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· July 21, 2026

Sagtec Global Limited Expands Strategic Partnership with Kinetic Seas to Launch Skilliks.AI Managed AI Memory Platform Across Southeast Asia

View original at globenewswire.com
Sagtec Global Limited Expands Strategic Partnership with Kinetic Seas to Launch Skilliks.AI Managed AI Memory Platform Across Southeast Asia KUALA LUMPUR, Malaysia, July 21, 2026 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT) ("Sagtec" or the "Company"), a Nasdaq-listed technology solutions provider, today an…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • More than 80% of new databases provisioned on the Neon platform are now created automatically by AI agents rather than by human users.

    60% confidence

  • Memory is one of the most valuable assets an organization provides to its AI systems; MaluDB is designed to remain permanently open source, allowing organizations of all sizes to deploy enterprise-grade AI memory with governance and transparency, and the Sagtec partnership positions Kinetic Seas to support growing enterprise AI adoption across Southeast Asia.

    60% confidence

  • Southeast Asia's businesses are adopting AI rapidly, but many organizations remain focused on maintaining control over where their institutional knowledge resides; through this partnership, Sagtec can provide enterprise AI memory infrastructure built on open-source technology and supported by regional hosting capabilities, complementing its investment in sovereign AI infrastructure.

    60% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com